These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 38420962)

  • 1. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
    Guthrie B; Rogers G; Livingstone S; Morales DR; Donnan P; Davis S; Youn JH; Hainsworth R; Thompson A; Payne K
    Health Soc Care Deliv Res; 2024 Feb; 12(4):1-275. PubMed ID: 38420962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study.
    Livingstone SJ; Guthrie B; McMinn M; Eke C; Donnan PT; Morales DR
    Lancet Healthy Longev; 2023 Jan; 4(1):e43-e53. PubMed ID: 36610448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study.
    Sahota O; Narayanasamy M; Bastounis A; Paskins Z; Bishop S; Langley T; Gittoes N; Davis S; Baily A; Holmes M; Leonardi-Bee J
    Health Technol Assess; 2024 Apr; 28(21):1-169. PubMed ID: 38634483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study.
    Livingstone SJ; Guthrie B; Donnan PT; Thompson A; Morales DR
    BMC Med; 2022 May; 20(1):152. PubMed ID: 35505353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study.
    Livingstone S; Morales DR; Donnan PT; Payne K; Thompson AJ; Youn JH; Guthrie B
    Lancet Healthy Longev; 2021 Jun; 2(6):e352-e361. PubMed ID: 34100008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.
    Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N
    Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population.
    Livingstone SJ; Morales DR; McMinn M; Eke C; Donnan P; Guthrie B
    BMJ Med; 2022; 1(1):e000316. PubMed ID: 36936595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.
    Robinson DE; Ali MS; Strauss VY; Elhussein L; Abrahamsen B; Arden NK; Ben-Shlomo Y; Caskey F; Cooper C; Dedman D; Delmestri A; Judge A; Javaid MK; Prieto-Alhambra D
    Health Technol Assess; 2021 Mar; 25(17):1-106. PubMed ID: 33739919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis.
    Horner DE; Davis S; Pandor A; Shulver H; Goodacre S; Hind D; Rex S; Gillett M; Bursnall M; Griffin X; Holland M; Hunt BJ; de Wit K; Bennett S; Pierce-Williams R
    Health Technol Assess; 2024 Apr; 28(20):1-166. PubMed ID: 38634415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
    Medina-Lara A; Grigore B; Lewis R; Peters J; Price S; Landa P; Robinson S; Neal R; Hamilton W; Spencer AE
    Health Technol Assess; 2020 Nov; 24(66):1-332. PubMed ID: 33252328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model.
    Crawford F; Chappell FM; Lewsey J; Riley R; Hawkins N; Nicolson D; Heggie R; Smith M; Horne M; Amanna A; Martin A; Gupta S; Gray K; Weller D; Brittenden J; Leese G
    Health Technol Assess; 2020 Nov; 24(62):1-198. PubMed ID: 33236718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UK.
    Thompson A; Youn JH; Guthrie B; Hainsworth R; Donnan P; Rogers G; Morales D; Payne K
    BMJ Open; 2023 Sep; 13(9):e063800. PubMed ID: 37734893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation.
    Cruickshank M; Hudson J; Hernández R; Aceves-Martins M; Quinton R; Gillies K; Aucott LS; Kennedy C; Manson P; Oliver N; Wu F; Bhattacharya S; Dhillo WS; Jayasena CN; Brazzelli M
    Health Technol Assess; 2024 Aug; 28(43):1-210. PubMed ID: 39248210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for patients with pilonidal sinus disease: PITSTOP, a mixed-methods evaluation.
    Brown S; Hind D; Strong E; Bradburn M; Din FVN; Lee E; Lee MJ; Lund J; Moffatt C; Morton J; Senapati A; Shackley P; Vaughan-Shaw P; Wysocki AP; Callaghan T; Jones H; Wickramasekera N;
    Health Technol Assess; 2024 Jul; 28(33):1-113. PubMed ID: 39045854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT.
    Barker KL; Newman M; Stallard N; Leal J; Minns Lowe C; Javaid MK; Noufaily A; Adhikari A; Hughes T; Smith DJ; Gandhi V; Cooper C; Lamb SE
    Health Technol Assess; 2019 Aug; 23(44):1-318. PubMed ID: 31456562
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.